The Prelieve Trial - Pilot Study to Assess Safety and Efficacy of a Novel Atrial Flow Regulator (AFR) in Heart Failure Patients

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 106 participants.

Also called NCT03030274

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 106 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03030274
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Belgium, Germany, Türkiye (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03030274. Allocation not applicable; no masking; primary purpose treatment. Start 2017-10-11 (actual); primary completion 2021-05-01 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Prelieve Trial - Pilot Study to Assess Safety and Efficacy of a Novel Atrial Flow Regulator (AFR) in Heart Failure Patients
Acronym
PRELIEVE
Condition
Heart Failure Low Output
Condition
Heart Failure
Intervention (Device)
Occlutech AFR device
Lead sponsor
Occlutech International AB (class: industry)

Record details

Record id
cardio:ct-nct03030274
Content hash
28b197e9ce68b9ca9b067a6d6f8a88b64e7c5a764093dab257681d95bc86a607